Ohio Lawmakers Consider Ibogaine Research As Veterans Push For New PTSD And Addiction Options
The discussion, led through Ohio’s Ibogaine Treatment Study Committee, reflects a broader shift in psychedelic policy.
Read More
How to Get Your Ketamine Clinic Cited by ChatGPT, Perplexity, and Gemini
Patients are asking AI tools for ketamine clinic recommendations — and most clinics are invisible. Here are the 6 ranking factors that actually earn citations, translated for ketamine clinic websites.
Read More
Lawmakers Push FDA to Speed Up Psychedelic Therapy Reviews
They asked the agency to advance evaluations of rapid acting therapeutics for PTSD, traumatic brain injury and related conditions.
Read More
TMS Therapy: A Complete 2026 Guide to Treatment, Cost, Insurance & Devices
Complete TMS therapy guide for 2026: FDA-cleared conditions, devices, insurance coverage, costs, side effects, and what to expect.
Read More
A Single Dose of Psilocybin May Leave Lasting Changes in the Brain
The findings add another piece to a central question: how can one guided experience produce changes that seem to outlast the drug itself?
Read More
Best GLP-1 Telehealth Programs of 2026: Compounded Semaglutide and Tirzepatide Compared
ShedRx, SkinnyRx, and Bodybuilding Health+ are the three GLP-1 telehealth programs worth comparing in 2026. ShedRx leads with brand-name Wegovy and Zepbound, the FDA-approved Foundayo pill, and a lose-10%-or-refund guarantee. SkinnyRx is the only one with oral tirzepatide tablets. Bodybuilding Health+ bundles GLP-1 with the men’s optimization stack from $99/month.
Read More
Watch a Berkeley Neuroscientist Describe Your Brain on Psychedelics in 101 Seconds
Psychedelic research is often discussed through the lens of treatment. But at UC Berkeley, neuroscientist Michael Silver is also asking a deeper scientific question. What can psychedelics teach us about the relationship between the brain, the mind, and consciousness? Silver, a professor of optometry and vision science and neuroscience, directs the UC Berkeley Center for […]
Read More
Could Psilocybin Help People Quit Smoking?
A new Johns Hopkins study suggests that psilocybin, the psychedelic compound in certain mushrooms, may help some people quit smoking.
Read More
From LSD Hearings to Trump’s Psychedelic Order: A 60 Year Timeline of Washington’s Evolving View of Psychedelics
Here's a timeline of Washington's evolving view on psychedelics. From LSD research to the War on Drugs to today’s push for mental health.
Read More
How Media Outlets Are Reacting to Trump’s Psychedelics Executive Order
Trump’s executive order on psychedelics pushed a once fringe issue into the center of health policy. The coverage shows a clear pattern.
Read More